Literature DB >> 32487805

An expanded role for dipeptidyl peptidase 4 in cell regulation.

James Ropa1, Hal E Broxmeyer.   

Abstract

PURPOSE OF REVIEW: Dipeptidyl peptidase 4 (DPP4) is a serine protease with diverse regulatory functions in healthy and diseased cells. Much remains unknown about the mechanisms and targets of DPP4. Here we discuss new studies exploring DPP4-mediated cellular regulation, provide an updated list of potential targets of DPP4, and discuss clinical implications of each. RECENT
FINDINGS: Recent studies have sought enhanced efficacy of targeting DPP4's role in regulating hematopoietic stem and progenitor cells for improved clinical application. Further studies have identified DPP4 functions in different cellular compartments and have proposed ways to target this protein in malignancy. These findings, together with an expanded list of putative extracellular, cell surface, and intracellular DPP4 targets, provide insight into new DPP4-mediated cell regulation.
SUMMARY: DPP4 posttranslationally modifies proteins and peptides with essential roles in hematopoietic cell regulation, stem cell transplantation, and malignancy. Targets include secreted signaling factors and may include membrane proteins and transcription factors critical for different hematopoietic functions. Knowing these targets and functions can provide insight into new regulatory roles for DPP4 that may be targeted to enhance transplantation, treat disease, and better understand different regulatory pathways of hematopoiesis.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32487805      PMCID: PMC9311264          DOI: 10.1097/MOH.0000000000000590

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.218


  56 in total

Review 1.  Hematopoietic cytokines.

Authors:  Donald Metcalf
Journal:  Blood       Date:  2008-01-15       Impact factor: 22.113

2.  Identifying neuropeptide Y (NPY) as the main stress-related substrate of dipeptidyl peptidase 4 (DPP4) in blood circulation.

Authors:  Leona Wagner; Florian Kaestner; Raik Wolf; Harald Stiller; Ulrich Heiser; Susanne Manhart; Torsten Hoffmann; Jens-Ulrich Rahfeld; Hans-Ulrich Demuth; Matthias Rothermundt; Stephan von Hörsten
Journal:  Neuropeptides       Date:  2016-02-27       Impact factor: 3.286

3.  In vivo DPP-4 inhibition to enhance engraftment of single-unit cord blood transplants in adults with hematological malignancies.

Authors:  Sherif S Farag; Shivani Srivastava; Steven Messina-Graham; Jennifer Schwartz; Michael J Robertson; Rafat Abonour; Kenneth Cornetta; Lisa Wood; Angie Secrest; R Matthew Strother; David R Jones; Hal E Broxmeyer
Journal:  Stem Cells Dev       Date:  2013-02-15       Impact factor: 3.272

4.  Progress towards improving homing and engraftment of hematopoietic stem cells for clinical transplantation.

Authors:  Xinxin Huang; Hal E Broxmeyer
Journal:  Curr Opin Hematol       Date:  2019-07       Impact factor: 3.284

5.  A peptidomics strategy to elucidate the proteolytic pathways that inactivate peptide hormones.

Authors:  Arthur D Tinoco; Yun-Gon Kim; Debarati M Tagore; Jessica Wiwczar; William S Lane; Nika N Danial; Alan Saghatelian
Journal:  Biochemistry       Date:  2011-02-22       Impact factor: 3.162

6.  Knockdown of ZNF268, which is transcriptionally downregulated by GATA-1, promotes proliferation of K562 cells.

Authors:  Yan Zeng; Wei Wang; Jian Ma; Xianguo Wang; Mingxiong Guo; Wenxin Li
Journal:  PLoS One       Date:  2012-01-03       Impact factor: 3.240

7.  Novel Antibody-Drug Conjugate with Anti-CD26 Humanized Monoclonal Antibody and Transcription Factor IIH (TFIIH) Inhibitor, Triptolide, Inhibits Tumor Growth via Impairing mRNA Synthesis.

Authors:  Mutsumi Hayashi; Hiroko Madokoro; Koji Yamada; Hiroko Nishida; Chikao Morimoto; Michiie Sakamoto; Hiroshi Yanagawa; Taketo Yamada
Journal:  Cancers (Basel)       Date:  2019-08-08       Impact factor: 6.639

Review 8.  Past, present, and future efforts to enhance the efficacy of cord blood hematopoietic cell transplantation.

Authors:  Xinxin Huang; Bin Guo; Maegan Capitano; Hal E Broxmeyer
Journal:  F1000Res       Date:  2019-10-31

9.  DPP8 is a novel therapeutic target for multiple myeloma.

Authors:  Tsutomu Sato; Ayumi Tatekoshi; Kohichi Takada; Satoshi Iyama; Yusuke Kamihara; Paras Jawaid; Mati Ur Rehman; Kyo Noguchi; Takashi Kondo; Sayaka Kajikawa; Kotaro Arita; Akinori Wada; Jun Murakami; Miho Arai; Ichiro Yasuda; Nam H Dang; Ryo Hatano; Noriaki Iwao; Kei Ohnuma; Chikao Morimoto
Journal:  Sci Rep       Date:  2019-12-02       Impact factor: 4.379

10.  Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirus.

Authors:  Hannah Kleine-Weber; Simon Schroeder; Nadine Krüger; Alexander Prokscha; Hassan Y Naim; Marcel A Müller; Christian Drosten; Stefan Pöhlmann; Markus Hoffmann
Journal:  Emerg Microbes Infect       Date:  2020-01-21       Impact factor: 7.163

View more
  7 in total

1.  Associated guilt: radiation/bystanders.

Authors:  Hal E Broxmeyer
Journal:  Blood       Date:  2021-06-17       Impact factor: 22.113

2.  Leukemia Inhibitory Factor Promotes Survival of Hematopoietic Progenitors Ex Vivo and Is Post-Translationally Regulated by DPP4.

Authors:  James Ropa; Scott Cooper; Hal E Broxmeyer
Journal:  Stem Cells       Date:  2022-03-31       Impact factor: 5.845

Review 3.  Consequences of coronavirus infections for primitive and mature hematopoietic cells: new insights and why it matters.

Authors:  James Ropa; Thao Trinh; Arafat Aljoufi; Hal E Broxmeyer
Journal:  Curr Opin Hematol       Date:  2021-07-01       Impact factor: 3.218

4.  Anagliptin promotes apoptosis in mouse colon carcinoma cells via MCT-4/lactate-mediated intracellular acidosis.

Authors:  Qi Li; Xiaoling Qin; Xiaotong Kou; Jingyu Li; Zhongsha Li; Chang Chen
Journal:  Exp Ther Med       Date:  2022-02-15       Impact factor: 2.447

5.  Dipeptidyl peptidase-4 cell surface expression marks an abundant adipose stem/progenitor cell population with high stemness in human white adipose tissue.

Authors:  Florian M Hatzmann; Sonja Großmann; Petra Waldegger; G Jan Wiegers; Markus Mandl; Tina Rauchenwald; Gerhard Pierer; Werner Zwerschke
Journal:  Adipocyte       Date:  2022-12       Impact factor: 3.553

Review 6.  Fate of Hematopoiesis During Aging. What Do We Really Know, and What are its Implications?

Authors:  Hal E Broxmeyer; Yan Liu; Reuben Kapur; Christie M Orschell; Arafat Aljoufi; James P Ropa; Thao Trinh; Sarah Burns; Maegan L Capitano
Journal:  Stem Cell Rev Rep       Date:  2020-11-03       Impact factor: 5.739

7.  Human Hematopoietic Stem, Progenitor, and Immune Cells Respond Ex Vivo to SARS-CoV-2 Spike Protein.

Authors:  James Ropa; Scott Cooper; Maegan L Capitano; Wouter Van't Hof; Hal E Broxmeyer
Journal:  Stem Cell Rev Rep       Date:  2020-10-21       Impact factor: 6.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.